Tyme Technologies Inc. (NASDAQ:TYME) Relative Strength Index (RSI) is 38.31, with weekly volatility at 4.84% and ATR at 0.11. The TYME stock’s 52-week price range has touched low of $0.85 and a $4.99 high. Intraday shares traded counted 1.28 million, which was 56.08% higher than its 30-day average trading volume of 2.92M. Its shares traded lower over the last trading session, losing -1.55% on 06/21/21. The shares fell to a low of $1.25 before closing at $1.27. TYME’s previous close was $1.29 while the outstanding shares total 154.17M. The firm has a beta of 1.03.
Investors have identified the Biotechnology company Tyme Technologies Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $223.77 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Tyme Technologies Inc. (TYME) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 109.66 million total, with 5.64 million as their total liabilities.
Potential earnings growth for Tyme Technologies Inc. (TYME)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/05/2021 quarter of the year, Tyme Technologies Inc. recorded a total of 6.25 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -8.65% coming in sequential stages and their sales for the 08/05/2021 quarter increasing by 6.11%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent -6.25 million trying to sell their products during the last quarter, with the result yielding a gross income of 19000.0. This allows shareholders to hold on to 154.17M with the recently reported earning now reading -0.04 cents per share. This is a figure that compared to analyst’s prediction for their 08/05/2021 (-0.03 cents a share).
Is the stock of TYME attractive?
In related news, Chief Science Officer, Hoffman Steve sold 41,250 shares of the company’s stock in a transaction that recorded on Jun 18. The sale was performed at an average price of 1.29, for a total value of 53,212. As the sale deal closes, the Chief Science Officer, Hoffman Steve now sold 41,250 shares of the company’s stock, valued at 54,862. Also, 10% Owner, Demurjian Michael sold 20,000 shares of the company’s stock in a deal that was recorded on Jun 14. The shares were price at an average price of 1.43 per share, with a total market value of 28,602. Following this completion of acquisition, the Chief Science Officer, Hoffman Steve now holds 41,250 shares of the company’s stock, valued at 65,175. In the last 6 months, insiders have changed their ownership in shares of company stock by 28.20%.